Stocks to buy in 2025 for long term: Cohance Lifesciences, Divi’s Lab among 5 stocks that could give 10-30% return
By Kshitij Anand, ETMarkets.com |
1/6
Brokerage Recommendations
Brokerages remain upbeat on select stocks across sectors, rolling out fresh Buy calls with healthy upside potential.
We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
2/6
Jefferies on Cohance Lifesciences
Jefferies on Cohance Lifesciences: Initiate Coverage| Buy| Target Rs 1150| LTP Rs 884| Upside 30%
Jefferies has initiated coverage on Cohance Lifesciences with a Buy rating and a target price of Rs 1,150. With the current market price at Rs 884, the brokerage sees an upside potential of 30%.
Jefferies has initiated coverage on Cohance Lifesciences with a Buy rating and a target price of Rs 1,150. With the current market price at Rs 884, the brokerage sees an upside potential of 30%.
3/6
Jefferies on Divi’s Laboratories
Jefferies on Divi’s Laboratories: Upgrade from Hold to Buy| Target Rs 7150 (vs Rs 6750)| LTP Rs 6150| Upside 16%
Jefferies has upgraded Divi’s Laboratories from Hold to Buy, revising the target price to Rs 7,150 from Rs 6,750 earlier. At the current market price of Rs 6,150, this implies an upside of 16%.
Jefferies has upgraded Divi’s Laboratories from Hold to Buy, revising the target price to Rs 7,150 from Rs 6,750 earlier. At the current market price of Rs 6,150, this implies an upside of 16%.
Amazon Top Deals
POWERED BY

Crompton Ozone 75 Litres Desert Air Cooler for home | Large & Easy Clean Ice Chamber | 4-Way Air Deflection | High Density Honeycomb Pads | Everlast Pump | Auto Fill| 3 Year Brand Warranty
₹9,798Buy Now43%
OFF

LG 32 L Convection Microwave Oven (MC3286BRUM, Black, 360° Motorised Rotisserie for Bar-be-queing, 301 Auto Cook Menu, Stainless steel cavity, Indian Cuisine, Tandoor Se, Steam Clean & Diet Fry)
₹18,780Buy Now22%
OFF
4/6
Motilal Oswal on KPIT Technologies
Motilal Oswal on KPIT Technologies: Initiating Coverage| Buy| Target Rs 1,600| LTP Rs 1196| Upside 33%
Motilal Oswal has initiated coverage on KPIT Technologies with a Buy rating and a target price of Rs 1,600. With the stock currently trading at Rs 1,196, the brokerage expects an upside of 33%.
Motilal Oswal has initiated coverage on KPIT Technologies with a Buy rating and a target price of Rs 1,600. With the stock currently trading at Rs 1,196, the brokerage expects an upside of 33%.
5/6
JM Financial on Eureka Forbes
JM Financial on Eureka Forbes: Buy| Target Rs 715| LTP Rs 550| Upside 30%
JM Financial has given a Buy call on Eureka Forbes with a target price of Rs 715. Based on the current market price of Rs 550, this indicates an upside potential of 30%.
JM Financial has given a Buy call on Eureka Forbes with a target price of Rs 715. Based on the current market price of Rs 550, this indicates an upside potential of 30%.
6/6
Choice Institutional Equities on Senores Pharma
Choice Institutional Equities on Senores Pharma Ltd: Buy| Target Rs 960| LTP Rs 723| Upside 32%
Choice Institutional Equities has initiated coverage on Senores Pharma with a Buy rating and a target price of Rs 960. Given the current market price of Rs 723, the brokerage foresees an upside of 32%.
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
Choice Institutional Equities has initiated coverage on Senores Pharma with a Buy rating and a target price of Rs 960. Given the current market price of Rs 723, the brokerage foresees an upside of 32%.
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)